AbbVie, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical Research and Development
Lobbying Interests:
Issues related to patient healthcare and pharmaceutical sales, research and development.
CEO Name:
Richard Gonzalez
Director, State Government Affairs
Pharmaceutical Research and Development
Lobbying Interests:
Issues related to patient healthcare and pharmaceutical sales, research and development.
CEO Name:
Richard Gonzalez
Director, State Government Affairs
Contact
CL
Christina Lee
1 North Waukegan Road, ABV1, 3-C
North Chicago, IL 60064
(847) 938-8522
christina.lee@abbvie.com
1 North Waukegan Road, ABV1, 3-C
North Chicago, IL 60064
(847) 938-8522
christina.lee@abbvie.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Christina Lee | Exclusive Duties N/A | Authorized On 10/5/2017 | Withdrawn On N/A |
| William J McCoshen | Exclusive Duties N/A | Authorized On 10/30/2017 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
12/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
For
Notification Date12/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
12/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
For
Notification Date12/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
LRB 4734/1
LRB 4734/1
Action Intended To Affect
Both Legislative matter and rule
Notification Date
11/9/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
11/9/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Biosimilar substitution for interchangeables, as deemed by the FDA
Biosimilar substitution for interchangeables, as deemed by the FDA
Action Intended To Affect
Both Legislative matter and rule
Notification Date
10/31/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
10/31/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2017 July - December $41,230.00 |
2018 January - June $25,163.17 |
2018 July - December $0.00 |
Total $66,393.17 |
| Total Hours Communicating | 2017 July - December 47.00 |
2018 January - June 50.00 |
2018 July - December 0.00 |
Total 97.00 |
| Total Hours Other | 2017 July - December 189.00 |
2018 January - June 80.00 |
2018 July - December 0.00 |
Total 269.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 20% |
2018 January - June 90% |
2018 July - December |
Total 45% |
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 10% |
2018 July - December |
Total 4% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 36% |
2018 January - June |
2018 July - December |
Total 23% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 44% |
2018 January - June |
2018 July - December |
Total 28% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication